Prohibition is a key driver of the new psychoactive substances (NPS) phenomenon

被引：9

作者：

Rolles, Stephen ^{[1
]}

Kushlick, Danny ^{[1
]}

机构：

[1] Transform Drug Policy Fdn, Bristol, Avon, England

来源：

ADDICTION | 2014年 / 109卷 / 10期

关键词：

Drugs; legal high; licensed; New Zealand; novel psychoactive substance; prohibition; recreational; regulation; retail;

D O I：

10.1111/add.12543

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

引用

收藏

页码：1589 / 1590

页数：2

相关论文

共 7 条

[1] Dunne P., 2013, COMMUNICATION
[2] Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
Hermanns-Clausen, Maren
Kneisel, Stefan
Szabo, Bela
Auwaerter, Volker
[J]. ADDICTION, 2013, 108 (03) : 534 - 544
[3] Newberry J, 2014, BMJ-BRIT MED J, V348, pg1534, DOI DOI 10.1136/BMJ.G1534
[4] Rolles S., 2009, WAR DRUGS BLUEPRINT
[5] UNODC, 2008, WORLD DRUG REP 2008, DOI DOI 10.18356/4713AA6F-EN
[6] A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand
Wilkins, Chris
[J]. ADDICTION, 2014, 109 (10) : 1580 - 1586
[7] Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample
Winstock, Adam R.
Barratt, Monica J.
[J]. DRUG AND ALCOHOL DEPENDENCE, 2013, 131 (1-2) : 106 - 111